In view of the above points, a retrospective analysis was carried out to further elucidate the spread pattern for different sites of first recurrence in Chinese triple negative breast cancer patients as compared to ERBB2+ and HR+/ERBB2- peers. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.